Advertisement

Topics

Samsung Bioepis teams up with Takeda to develop original biotech drugs

20:41 EDT 20 Aug 2017 | Reuters

SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.

Original Article: Samsung Bioepis teams up with Takeda to develop original biotech drugs

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis teams up with Takeda to develop original biotech drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...